U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180433) titled 'Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer' on June 12.
Brief Summary: Breast cancer is the most common type of cancer in Norwegian women, with 4,224 new cases in 2022. More precise diagnosis are expected to result in more accurate assessment of treatment effect, and to contribute to both providing better treatment and reducing overtreatment. Fibroblast activating protein (FAP) is expressed in the tumor stroma of 90% of all epithelial-based tumors, including breast tumors. Inhibitors for this protein (FAPI) has been developed for use as radioactive tracers. Breast tumors of various histopathological types, and loca...